Physician profile
Melvin P Palalay
NPI 1508833971
$20,228.48
in general payments reported to CMS, 2019-2025
96 companies · $4,809 in 2025
The $4,809 reported for 2025 was more than what 81% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,915 · 2020: $1,864 · 2021: $2,342 · 2022: $2,008 · 2023: $3,374 · 2024: $3,916 · 2025: $4,809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,747.75 |
| Education | $351.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,734.68 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $1,468.79 | 2019-2025 | Imfinzi, Enhertu, Tagrisso |
| E.R. Squibb & Sons, L.L.C. | $1,457.70 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Janssen Biotech, INC. | $1,054.07 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Incyte Corporation | $1,008.21 | 2019-2025 | Jakafi, Niktimvo, Pemazyre |
| Abbvie INC. | $767.62 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $750.14 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $703.83 | 2019-2025 | Keytruda, Welireg, Lenvima |
| Seagen INC. | $524.24 | 2019-2023 | Adcetris, Padcev |
| Genzyme Corporation | $453.60 | 2019-2025 | |
| Lilly USA, LLC | $414.13 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Karyopharm Therapeutics INC. | $406.00 | 2020-2025 | Xpovio |
| Emd Serono, INC. | $373.44 | 2021-2025 | Tepmetko |
| Exelixis INC. | $371.40 | 2019-2025 | Cabometyx |
| Kite Pharma, INC. | $369.07 | 2020-2025 | Yescarta |
Show all 96 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $369.00 | 2019-2025 | Padcev, Xtandi, Vyloy |
| Daiichi Sankyo INC. | $366.33 | 2020-2025 | Enhertu, Vanflyta, Datroway |
| Eisai INC. | $361.12 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $313.76 | 2022-2025 | Libtayo, Lynozyfic |
| Jazz Pharmaceuticals INC. | $312.56 | 2023-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $290.18 | 2019-2022 | |
| Coherus Oncology, INC. | $244.79 | 2020-2025 | Loqtorzi, Udenyca |
| Springworks Therapeutics, INC. | $236.65 | 2024-2025 | Ogsiveo |
| Ipsen Biopharmaceuticals, INC | $236.65 | 2021-2025 | Onivyde, Somatuline Depot |
| Amgen INC. | $233.86 | 2019-2025 | Vectibix, Kyprolis, Nplate |
| Puma Biotechnology, INC. | $189.88 | 2020-2025 | |
| Sobi, INC | $177.85 | 2021-2025 | |
| Genentech USA, INC. | $177.64 | 2021-2025 | Venclexta, Columvi, Hemlibra |
| Caris Mpi, INC. | $175.21 | 2025 | Mi Cancer Seek |
| Alexion Pharmaceuticals, INC. | $172.62 | 2019-2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.49 | 2019-2025 | Gilotrif |
| US Oncology Corporate, INC. | $158.69 | 2023 | |
| Glaxosmithkline, LLC. | $157.25 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Celgene Corporation | $152.77 | 2019-2025 | Reblozyl, Opdualag |
| Gilead Sciences, INC. | $152.46 | 2019-2025 | Trodelvy |
| Blueprint Medicines Corporation | $152.13 | 2020-2025 | Ayvakit |
| Adaptive Biotechnologies Corporation | $151.88 | 2023-2025 | Clonoseq |
| Takeda Pharmaceuticals U.S.A., INC. | $137.22 | 2022-2025 | Ninlaro |
| Taiho Oncology, INC. | $136.31 | 2020-2025 | |
| Stemline Therapeutics INC. | $132.20 | 2024-2025 | Orserdu |
| Cardinal Health 108 LLC | $128.37 | 2022 | |
| Rigel Pharmaceuticals, INC. | $125.77 | 2020-2025 | Rezlidhia, Gavreto, Tavalisse |
| Biomarin Pharmaceutical INC. | $119.86 | 2025 | Roctavian |
| Tempus Ai, INC | $115.17 | 2024 | Xt Cdx |
| Aveo Pharmaceuticals, INC. | $112.05 | 2025 | |
| Eusa Pharma (US) LLC | $105.54 | 2019-2021 | |
| Spectrum Pharmaceuticals INC. | $105.25 | 2023-2025 | Rolvedon |
| Sanofi-Aventis U.S. LLC | $96.00 | 2023 | |
| Genmab U.S., INC. | $88.46 | 2023-2025 | Epkinly |
| Acrotech Biopharma INC. | $85.81 | 2021-2025 | Beleodaq |
| Fennec Pharmaceuticals, INC. | $84.86 | 2024-2025 | Fyarro, Pedmark |
| Apellis Pharmaceuticals, INC. | $84.20 | 2023-2025 | Empaveli |
| Azurity Pharmaceuticals, INC. | $83.41 | 2025 | Danziten |
| Array Biopharma INC | $71.94 | 2022-2023 | Mektovi, Lorbrena, Braftovi |
| Dova Pharmaceuticals | $70.84 | 2020-2021 | |
| Beigene USA, INC. | $70.73 | 2022-2025 | Tevimbra, Brukinsa |
| Pharmacosmos Therapeutics INC. | $69.82 | 2024-2025 | Monoferric, Cosela |
| Bayer Healthcare Pharmaceuticals INC. | $68.74 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $63.55 | 2020-2021 | |
| Novocure INC. | $61.65 | 2023-2025 | Optune Gio, Optune |
| Menarini Silicon Biosystems, INC. | $61.56 | 2025 | |
| Syndax Pharmaceuticals, INC. | $60.70 | 2025 | |
| Pharmaessentia USA Corporation | $60.62 | 2025 | Besremi |
| Tersera Therapeutics LLC | $60.40 | 2022-2025 | Zoladex |
| Recordati_rare_diseases_inc. | $56.97 | 2024-2025 | Sylvant |
| Foundation Medicine, INC. | $55.77 | 2020-2023 | |
| Sun Pharmaceutical Industries INC. | $55.28 | 2021-2025 | |
| Servier Pharmaceuticals LLC | $51.64 | 2023-2024 | |
| Chiesi USA, INC. | $51.52 | 2024-2025 | Ferriprox |
| Mylan Institutional INC. | $50.14 | 2023 | Ogivri, Fulphila |
| Insmed, INC. | $50.00 | 2019 | |
| Kyowa Kirin, INC. | $49.44 | 2023 | Poteligeo |
| Alnylam Pharmaceuticals INC. | $46.26 | 2024 | Givlaari |
| Novo Nordisk INC | $37.40 | 2022-2025 | |
| Adc Therapeutics America, INC. | $37.09 | 2022 | |
| Beone Medicines USA, INC. | $31.45 | 2025 | Brukinsa |
| Cti Biopharma Corp. | $28.55 | 2022 | |
| Mirati Therapeutics, INC. | $28.48 | 2024 | Krazati |
| Immunitybio, INC. | $24.54 | 2025 | |
| Verity Pharmaceuticals INC. | $24.04 | 2025 | Trelstar |
| Partner Therapeutics, INC. | $23.03 | 2019 | |
| Sirtex Medical INC | $22.11 | 2024 | Sir-Spheres Microspheres |
| Epizyme, INC. | $21.46 | 2022 | |
| Deciphera Pharmaceuticals INC. | $21.04 | 2022 | |
| Aadi Bioscience, INC. | $21.04 | 2024 | Fyarro |
| Myriad Genetic Laboratories, INC. | $20.71 | 2021 | |
| Teleflex LLC | $19.18 | 2024 | Arrow |
| Clinigen, INC. | $18.69 | 2019 | |
| Morphosys, US INC. | $18.66 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.09 | 2020-2021 | |
| Horizon Therapeutics Plc | $16.59 | 2021 | |
| Celltrion USA INC. | $15.25 | 2024 | Vegzelma |
| Verastem, INC. | $15.19 | 2020 | |
| Allergan, INC. | $14.90 | 2019 | |
| Aurobindo Pharma USA, INC. | $12.46 | 2020 | |
| Secura Bio, INC. | $9.79 | 2020 |
Drugs and devices associated with these payments
Opdivo $566Imfinzi $478Jakafi $449Enhertu $435Xtandi $368Xpovio $278Opdualag $268Pluvicto $262Zepzelca $260Venclexta $259Libtayo $259Erleada $252Ogsiveo $237Padcev $229Lenvima $222Epkinly $222Lutathera $200Cabometyx $195Niktimvo $190Verzenio $184Sarclisa $183Kisqali $180Mi Cancer Seek $175Keytruda $162Pemazyre $159Monjuvi $159Orgovyx $159Clonoseq $152Udenyca $145Jaypirca $142Ibrance $139Tagrisso $135Orserdu $132Ultomiris $131Rybrevant $125Vyndaqel $125Ninlaro $123Scemblix $123Onivyde $120Roctavian $120Vanflyta $116Vonjo $115Imbruvica $113Fotivda $112Adcetris $112Rolvedon $105Fabhalta $104Bosulif $99.22Talzenna $96.73Jevtana $96.00Elrexfio $96.00Reblozyl $90.80Gilotrif $85.60Empaveli $84.20Danziten $83.41Tavalisse $82.24Rezlidhia $82.24Carvykti $81.98Loqtorzi $77.79Darzalex $76.49Xt Cdx $67.35Yescarta $65.52Fyarro $65.41Ojjaara $64.98Cellsearch $61.56Besremi $60.62Comirnaty $60.04Sylvant $56.97Tecvayli $56.30Emrelis $54.01Ziihera $52.75Monoferric $51.78Tibsovo $51.64Ferriprox $51.52Ogivri $50.14Fulphila $50.14Poteligeo $49.44Zejula $49.15Jemperli $49.15Brukinsa $48.94Besponsa $47.94Optune Gio $47.94Tepmetko $47.16Ayvakit $46.71Givlaari $46.26Lupron Depot $46.03Nerlynx $45.88Doptelet $45.50Gavreto $44.03Datroway $43.08Paxlovid $42.35Promacta $41.50Pedmark $40.49Lonsurf $40.44Inqovi $40.44Xyntha $39.99Benefix $39.99Welireg $39.16Optune $37.68Gazyva $36.57
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melvin Palalay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.